Location of Repository

Twenty-first century brain banking. Processing brains for research: the Columbia University methods

By Jean Paul G. Vonsattel, Maria Pilar del Amaya and Christian E. Keller


Carefully categorized postmortem human brains are crucial for research. The lack of generally accepted methods for processing human postmortem brains for research persists. Thus, brain banking is essential; however, it cannot be achieved at the cost of the teaching mission of the academic institution by routing brains away from residency programs, particularly when the autopsy rate is steadily decreasing. A consensus must be reached whereby a brain can be utilizable for diagnosis, research, and teaching. The best diagnostic categorization possible must be secured and the yield of samples for basic investigation maximized. This report focuses on integrated, novel methods currently applied at the New York Brain Bank, Columbia University, New York, which are designed to reach accurate neuropathological diagnosis, optimize the yield of samples, and process fresh-frozen samples suitable for a wide range of modern investigations. The brains donated for research are processed as soon as possible after death. The prosector must have a good command of the neuroanatomy, neuropathology, and the protocol. One half of each brain is immersed in formalin for performing the thorough neuropathologic evaluation, which is combined with the teaching task. The contralateral half is extensively dissected at the fresh state. The anatomical origin of each sample is recorded using the map of Brodmann for the cortical samples. The samples are frozen at −160°C, barcode labeled, and ready for immediate disbursement once categorized diagnostically. A rigorous organization of freezer space, coupled to an electronic tracking system with its attached software, fosters efficient access for retrieval within minutes of any specific frozen samples in storage. This report describes how this achievement is feasible with emphasis on the actual processing of brains donated for research

Topics: Methods Report
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:2292479
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (1993). A brain bank in a neuropathology laboratory (with some emphasis on diagnostic criteria).
    2. (1988). A comparison of methodologies for the study of functional transmitter neurochemistry in human brain.
    3. (1963). An experimental study of post-mortem alterations in the granular layer of the cerebellar cortex.
    4. (1995). An improved approach to prepare human brains for research.
    5. (1988). Are postmortem biochemical studies of human brain worthwhile? Biochem Soc Trans
    6. (1995). Autopsy training programs. To right a wrong. Arch Pathol Lab Med 119:289–291
    7. (1908). Beitra ¨ge zur histologischen Lokalisation der Grosshirnrinde.
    8. (1994). Brain at necropsy: to fix or not to fix?
    9. (2007). Brain bank of the Brazilian aging brain study group––a milestone reached and more than 1,600 collected brains.
    10. (1992). Brain banking and the human hypothalamus––factors to match for, pitfalls and potentials.
    11. (2003). Brain banking in the United States.
    12. (1989). Brain donation.
    13. (1985). Brain glutamate decarboxylase in Parkinson’s disease with particular reference to a premortem severity index.
    14. (2007). Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe study.
    15. (1992). Changes in relative levels of specific brain mRNA species associatedwithschizophreniaanddepression.MolBrainRes12:163–171
    16. (1997). Criteria for Alzheimer’s disease and the nosology of dementia with Lewy bodies.
    17. (1979). Differential effects of agonal status on measurements of GABA and glutamate decarboxylase in human post-mortem brain tissue from control and Huntington’s chorea subjects.
    18. (1996). DNA damage and apoptosis in Alzheimer’s disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.
    19. (1975). Eckerna ¨s SA, Sundwall A
    20. (1979). Effect of anoxia and ischemia on ribonuclease activity in brain.
    21. (1995). Effect of postmortem interval on in situ end-labeling of DNA oligonucleosomes.
    22. (1991). Effect of pre- and postmortem variables on specific mRNA levels in human brain.
    23. (2001). Gene expression profiling in the post-mortem human brain––no cause for dismay.
    24. (1993). Heat shock protein (hsx70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state.
    25. (2002). Hippocampal neurons in schizophrenia.
    26. (2007). How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.
    27. (1983). Human brain neurochemistry––some postmortem problems.
    28. (1993). Human neuro-specimen banking 1961–1992.
    29. (1992). In situ hybridization demonstrates the stability of mRNA in post-mortem rat tissues.
    30. (1996). In situ labeling of dying cortical neurons in normal aging and in Alzheimer’s disease: correlations with senile plaques and disease progression.
    31. (1993). Neurochemical-clinical correlates in Huntington’s disease––applications of brain banking techniques.
    32. (1992). On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer’s disease.
    33. (1993). Pathological assessment of movement disorders: requirements for documentation in brain banks.
    34. (1993). Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa.
    35. (1993). Pre- and postmortem influences on brain RNA.
    36. (1991). Premortem and postmortem measurement to study structure with function: a human brain collection.
    37. (1997). Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer’s Disease Research Center experience.
    38. (1994). Somatostatin messenger RNAcontaining neurons in Alzheimer’s disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
    39. (1987). Stability of brain RNA post mortem: effect of Alzheimer’s disease.
    40. (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
    41. (1993). Staging of Alzheimer related cortical destruction.
    42. (2003). Staging of brain pathology related to sporadic Parkinson’s disease.
    43. (1991). Terminal coma affects messenger RNA detection in post mortem human temporal cortex.
    44. (1991). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease.
    45. (1981). The declining autopsy rate and its significance for neuropathology: two viewpoints.
    46. (1993). The development of a brain bank.
    47. (1997). The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease
    48. (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation.
    49. (1995). Tissue pH as an indicator of mRNA preservation in human post-mortem brain.
    50. (1989). Wanted: normal brains.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.